Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease

NCT06780683 · clinicaltrials.gov ↗

RECRUITING

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Upadacitinib

Sponsor

Xiang Gao